In vitro biomimetic HPLC and in vivo characterisation of GM6, an endogenous regulator peptide drug candidate for amyotrophic lateral sclerosis. ADMET DMPK [Internet]. 2018 Jun. 16 [cited 2026 May 21];6(2):176-89. Available from: https://pub.iapchem.org/ojs/index.php/admet/article/view/547